| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |